an eye opener
----------
From: Barbara Patterson <[log in to unmask]>
To: Multiple recipients of list PARKINSN <[log in to unmask]>
Subject: Dr.'s Lang & Lozano, New England Journal of Medicine
Date: Sunday, November 01, 1998 4:56 PM
After reading about this two-part article on this list, I obtained a copy
of it from the Health Sciences Library at McMaster University. I haven't
Lang, A. E. & Lozano, A. M. Medical progress: Parkinson's disease.
First of two parts. New England Journal of Medicine, 1998; 339:1044-1063.
"Age is the single most consistent risk factor and with the increasing
age of the general population, the prevalence of Parkinson's Disease will
rise steadily in the future. The impact of the disease is indicated by
the fact that mortality is two to five times as high among affected
persons as among age-matched controls resulting in a marked reduction in
life expectancy." (Page 1044)
disease, and dementia) are projected to surpass cancer as the second
most
common cause of death among the elderly by the year 2040." (Page 1044)
Reference:
Lilienfeld, D. E., Perl, D. P. Projected neurodegenerative disease
mortality in the United States, 1990-2040. Neuroepidemiology 1993;
12:219-28.
"Underdiagnosis is common; in recent door-to-door studies, up to 24
percent of cases were newly detected at the time of the survey." (Page
1044)
De Rijk, M.C., Tzouri, C., Breteler, M.M.B., et al. Prevalence of
parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON
Collaborative Study. J Neurol Neurosurg Psychiatry 1997;62:10-5.
===========================================================================
Barbara Patterson
[log in to unmask]
HSC 2J22 905-525-9140, ext. 22403
School of Nursing
===========================================================================
